Robert Engstrom
Ophthalmology · Encino, CANPI 1689663395
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,901 of the $4,991 with a category attached, or 78.2%. 14 manufacturers reported payments, led by Genentech, Inc. at 39.3% of the total. Reporting peaked in 2019 at $2,581 and has fallen 86.1% since, to $360 in 2023.
Across 104 payments — averaging $47.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2K
- AbbVie$904
- Regeneron Healthcare Solutions, Inc.$682
- Genentech USA, Inc.$641
- Alimera Sciences, Inc.$217
- Bausch & Lomb Americas Inc.$167
- plus $415 from 8 others
Across 175 payments — averaging $19,562 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$3.4M
- AstraZeneca$34K
What the payments were for
- Travel & lodging$1,04821%
- Food & beverage$3,90178%
- Entertainment$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 10 | $1,963 |
| AbbVie(2 entities) | 30 | $904 |
| Regeneron Healthcare Solutions, Inc. | 24 | $682 |
| Genentech USA, Inc. | 20 | $641 |
| Alimera Sciences, Inc. | 9 | $217 |
| Bausch & Lomb Americas Inc. | 2 | $167 |
| Novartis | 1 | $121 |
| Dutch Ophthalmic, USA | 1 | $118 |
| Optos, Inc. | 1 | $42 |
| Eyepoint US, Inc. | 2 | $41 |
| Biogen | 1 | $28 |
| Apellis Pharmaceuticals, Inc. | 1 | $25 |
| Coherus Oncology, Inc. | 1 | $22 |
| Spark Therapeutics, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered Product$1,831
- VABYSMO$268
- Lucentis$236
- STELLARIS$146
- EYLEA$122
- EVA Ophthalmic Surgical System$118
- Iluvien$106
How this compares
$4,991 in reported general payments places this provider in the 75th percentile of 2,513 ophthalmology providers in California.
Other ophthalmology in Encino
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.